Skip to Main Content

Paper Details

Pharmacogenomic Biomarkers in US FDA-Approved Drug Labels (2000-2020).
J Pers Med
23
2021
Author NameAffiliation
Rachel CeccarelliHarvard Pilgrim Health Care Institute and Harvard Medical School
Christine Y LuHarvard Pilgrim Health Care Institute and Harvard Medical School
  • 1 - 2

Datasets

PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink